U.S. Markets closed

Amicus Therapeutics reports 3Q loss

CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Wednesday reported a loss of $111.7 million in its third quarter.

On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 69 cents. Losses, adjusted for one-time gains and costs, came to 41 cents per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The pharmaceutical company posted revenue of $10.9 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $9.9 million.

Amicus Therapeutics shares have nearly tripled since the beginning of the year. The stock has increased 91 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD